Skip to content

Insulet PODD EV / sales

EV / sales at other companies

Eli Lilly logo
Eli LillyLLY
11.9×-4.0×
Medtronic logo
MedtronicMDT
3.6×-0.4×
AptarGroup logo
AptarGroupATR
2.4×-0.6×
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
5.5×0.0×
Abbott logo
AbbottABT
4.6×-1.0×
Halozyme Therapeutics logo
Halozyme TherapeuticsHALO
6.3×-2.2×

Other financials

Income statement

See full
Revenue$761.7M+33.9%
Gross profit$529.0M+29.3%
Operating income$122.1M+37.5%
Net income$91.1M+157%
EPS (diluted)$1.30+160%

Balance sheet

See full
Cash & equivalents$480.4M-62.6%
Total debt$969.7M-45.5%
Total equity$1.3B-2.1%
Total assets$3.0B-15.1%

Cash flow

See full
Operating cash flow$113.8M+78.4%
CapEx$24.3M+97.6%
Free cash flow$89.5M+73.8%

Valuation

See full
Market cap$10.1B-19.9%
Enterprise value$10.59B-19.4%
P/E33.3×+2.0×
P/S3.5×-2.3×

Profitability

See full
Gross margin71%+0.6pp
Operating margin17.5%+2.0pp
Net margin10.4%-7.9pp
FCF margin14.3%+1.1pp

Returns & leverage

See full
Return on equity23%-14.9pp
Debt / equity0.7×-0.6×
Current ratio2.5×-2.0×

Where this comes from

Calculated from Insulet’s reported figures.

Based on the most recent quarter.

The official record: Insulet’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Insulet's ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Insulet's EV / sales?
Insulet (PODD) reported EV / sales of 5.3× in Q1 2026.
How has Insulet's EV / sales changed year-over-year?
Insulet's EV / sales decreased by 38.9% year-over-year, from 8.6× to 5.3×.
What is the long-term trend for Insulet's EV / sales?
Over 5 years (2020 to 2025), Insulet's EV / sales has grown at a -17.5% compound annual growth rate (CAGR), from 19.7× to 7.5×.
What does EV / sales mean?
What the whole business costs relative to its annual sales.
How do you interpret EV / sales?
A fallback valuation gauge for pre-profit or cyclical firms. Like P/S, only comparable across similar-margin businesses, but it accounts for debt and cash unlike P/S.
How does EV / sales compare across companies?
Compare within a margin cohort; the debt-and-cash adjustment makes it cleaner than P/S for leveraged firms.